| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | $2.3B | $3.4B | $3.1B | $1.6B | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | $0.8B | $0.8B | $1.1B | $1.0B | $0.5B | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.6B | $0.8B | $0.7B | $0.3B | — |
| Operating Income | $-3.1B | $-0.1B | $-0.1B | $-0.0B | $0.1B | $-0.0B |
| Net Income | $-3.1B | $-0.2B | $-0.3B | $-0.1B | $-0.0B | $-0.0B |
| EPS (Basic) | $-5.87 | $-0.29 | $-0.70 | $-0.14 | $-0.08 | — |
| EPS (Diluted) | $-5.87 | $-0.29 | $-0.70 | $-0.14 | $-0.08 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $4.6B | $8.2B | $10.8B | $11.2B | $11.0B | $1.0B |
| Current Assets | $1.1B | $1.3B | $2.8B | $2.8B | $2.5B | $0.0B |
| Cash & Equivalents | $0.3B | $0.3B | $0.4B | $0.3B | $0.4B | $0.0B |
| Total Liabilities | $3.5B | $3.9B | $6.0B | $6.1B | $6.1B | $0.0B |
| Current Liabilities | $0.9B | $0.9B | $2.2B | $2.3B | $2.1B | $0.0B |
| Stockholders' Equity | $1.0B | $4.3B | $4.5B | $4.4B | $4.1B | $0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.3B | $0.4B | $0.3B | $0.1B | $-0.0B |
| Investing Cash Flow | $-0.1B | $0.8B | $-0.2B | $-0.2B | $-1.9B | $-1.0B |
| Capital Expenditures | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | — |
| Financing Cash Flow | $-0.3B | $-1.1B | $-0.2B | $0.1B | $2.4B | $1.0B |